期刊文献+

长链非编码RNA CCAT1调控MAPK信号通路对于胶质瘤细胞的影响

Long non-coding RNA CCAT1affects glioma by regulating MAPK signaling pathway
下载PDF
导出
摘要 目的探讨长链非编码RNA CCAT1表达对人胶质瘤细胞U251增殖、侵袭能力的影响及其作用机制。方法选取人胶质瘤细胞U251进行转染实验,分为空白组、sh-NC组和sh-CCAT1组;利用实时荧光定量qRT-PCR检测抑制效果;采用MMT、Transwell试验检测下调CCAT1对于胶质瘤细胞增殖、侵袭能力的影响;利用Western blot检测丝裂原活化蛋白激酶(MAPK)信号通路相关分子的表达变化。结果在转染48h后,sh-CCAT1组CCAT1的表达较NC组和sh-NC组显著降低(P<0.05);CCAT1下调后,胶质瘤细胞U251的增殖、侵袭能力显著下降(P<0.05),蛋白表达检测表明,CCAT1下调显著抑制MAPK信号通路分子的表达。结论CCAT1可能通过MAPK通路抑制胶质瘤的增殖和侵袭。 Objective To investigate the expression of long noncoding RNA(lncRNA)CCAT1in glioma cells U251,and its role in proliferation and invasion.Methods Human glioma cells U251were transfected by shRNA and were divided into three groups:blank group,sh-NC group and sh-CCAT1group.Real-time quantitative PCR was used to detect the inhibition effect.The effects of down-regulation of CCAT1on the proliferation and invasion of glioma cells were detected by MTT and Transwell tests.Western blot was used to detect the expression changes of related molecules in the mitogen-activated protein kinase(MAPK)signaling pathway.Results After transfection,the expression of CCAT1in sh-CCAT1group was significantly lower than that in NC group and sh-NC group(P<0.05);After the downregulation of CCAT1,the proliferation and invasion ability of glioma cells U251significantly decreased(P<0.05),the protein expression detection showed that the down-regulation of CCAT1significantly inhibited the molecular expression of MAPK signaling pathway.Conclusion CCAT1 may inhibit the proliferation and invasion of glioma through the MAPK signaling pathway.
作者 王春辉 孟繁凯 费邵阳 陈莫 郑林杰 WANG Chun-hui;MENG Fankai;FEI Shao-yang(Jilin Province People’s Hospital,Changchun130021,China)
出处 《中国实验诊断学》 2020年第10期1693-1697,共5页 Chinese Journal of Laboratory Diagnosis
基金 吉林省科技厅基础处自然科学基金资助(20180101300JC)。
关键词 长链非编码RNA CCAT1 胶质瘤 增殖 MAPK信号通路 LncRNA CCAT1 glioma proliferation MAPK Signaling Pathway
  • 相关文献

参考文献2

二级参考文献23

  • 1李新钢,宫崧峰,李刚,徐淑军,王东海,张元鹏,何仕玥.脂膜微囊靶向性聚集于颅内C6胶质瘤的实验研究[J].中华神经医学杂志,2006,5(3):237-239. 被引量:3
  • 2莫万彬,杜贻庆,罗毅,阳永东,唐景峰,周晓坤.阿霉素控缓释局部化疗在颅内恶性肿瘤术中的应用[J].华夏医学,2006,19(1):65-66. 被引量:8
  • 3Singh SK,Hawkins C,Clarke ID,et al Identification of human brain tumor mitiating cells [ J ]. Nature,2004,432 ( 7015 ) :396-401.
  • 4Lawson H, Sampath P, Bohan E, et al. Interstitial chemotherapy formalignant gliomas : the Johns Hopkins experience [ J ]. Neurooncol, 2007,83 (1) :61-70.
  • 5Hochberg FH, Pruitt A. Assumptions in the radiotherapy of glioblastoma [ J ]. Neurology, 1980,30 (9) :907-911.
  • 6Bodell WJ, Bodell AP, Giannini DD, et al. Levels and distribution of BCNU in GBM tumors following intratumoral injection of DTI- 015 (BCNU-ethanol) [J]. Neurooncol,2007,9(1 ) :12-19.
  • 7Boiardi A, Bartolomei M, Silvani A, et al. Intratumoral delivery of mitoxantrone in association with 90-Y radioimmunotherapy (RIT) in recurrent glioblastoma[ J]. J Neurooncol,2005,72(2) : 125-131.
  • 8Mamelak AN, Rosenfeld S, Bucholz R ,et al. Phase I singledose study of intracavitary-administered iodine-131-TM-601 in adults with recurrent high-grade glioma [ J ]. J Clin Oncol, 2006,24 ( 22 ) : 3644-3650.
  • 9Menei P, Monteru-Menei C, Venier MC, et al. Drug delivery into the brain using poly ( lactide-co-glycolide ) microspheres [ J ]. Expert Opin Drug Deliv,2005,2(2) :363-376.
  • 10Attenello FJ,Mukherjee D,Datoo G,et al. Use of Ghadel (BCNU) wafer in the surgical treatment of malignant glioma:a 10-year Interstitial chemotherapy [ J ]. Ann Surg Oncol, 2008, 15 ( 10 ) : 2887-2893.

共引文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部